Trade Mark Journal No.2026/006 6 February 2026
WO0000001891078 (35,42)
Office of origin: United States of America
Date of International Registration:3 July 2025
Date of designation in the UK:
3 July 2025
International priority date claimed: 24 April 2025
(United States of America)
(99153749)
- Class 35
- Promoting collaboration within the scientific, research and medical communities to optimize clinical care and outcomes for cancer patients, identify predictive and prognostic markers to further advance molecular profiling and cancer care, promote clinical trials, generate scientific publications, and generate and document additional medical evidence for the appropriate use and impact of molecular profiling for cancer; promoting the exchange of information and resources within the scientific research and medical communities to optimize clinical care and outcomes for cancer patients, identify predictive and prognostic markers to further advance molecular profiling and cancer care, promote clinical trials, generate scientific publications, and generate and document additional medical evidence for the appropriate use and impact of molecular profiling for cancer.
- Class 42
- Medical research services in the field of cancer; providing a database of combined clinical-genomic data including clinical outcomes for research; providing scientific collaboration services, namely, facilitating meeting in the field of cancer research.
Caris MPI, Inc.
Representative: Haseltine Lake Kempner LLP, Fountain House, 4 South Parade Leeds LS1 5QX UNITED KINGDOM